Trial Profile

Randomized, Double-blind, Parallel-group, Phase 1 Study.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 14 Sep 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Infliximab (Primary)
Indications Ankylosing spondylitis
Focus Pharmacokinetics; Registrational
Acronyms PLANETAS
Sponsors Celltrion

Most Recent Events

09 Sep 2020 Results of two trials ( PLANETRA and PLANETAS)published in the Journal of Clinical Pharmacology
13 Jun 2015 Results of retrospective analysis of pooled data from PLANETAS and PLANETRA trials presented at the 16th Annual Congress of the European League Against Rheumatism.
30 Oct 2013 Efficacy results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com